Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Arantzazu Barquín"'
Autor:
Juan José Serrano Domingo, Teresa Alonso Gordoa, Javier Lorca Álvaro, Javier Molina-Cerrillo, Arantzazu Barquín García, Olga Martínez Sáez, Javier Burgos Revilla, Alfredo Carrato, Sara Álvarez Rodríguez
Publikováno v:
Therapeutic Advances in Urology, Vol 13 (2021)
Introduction: Androgenic deprivation therapies have been linked to the development of metabolic syndrome (MS) and cardiovascular diseases, which may lead to a poorer survival in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC). W
Externí odkaz:
https://doaj.org/article/bd7dd74fc3904ca98d86d7a190c3ecec
Autor:
Elena Sevillano Fernández, Rodrigo Madurga de Lacalle, Juan Francisco Rodriguez Moreno, Arantzazu Barquín García, Mónica Yagüe Fernández, Paloma Navarro Alcaraz, María Barba Llacer, Miguel Quiralte Pulido, Jesús García-Donás Jiménez
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 15, p 4483 (2022)
Fibroblast growth factor receptor (FGFR) genomic alterations (GAs) represent an actionable target, key to the pathogenesis of some urothelial cancers (UCs). Though FGFR GAs are common in noninvasive UC, little is known about their role in the metasta
Externí odkaz:
https://doaj.org/article/dc11412cdbff443c821cf74bda6ffce2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
María Dolores Fenor, Sergio Ruiz-Llorente, Juan Francisco Rodríguez-Moreno, Eduardo Caleiras, Juan Carlos Torrego, Elena Sevillano-Fernández, Paloma Navarro, Mónica Yagüe-Fernández, Sandra Amarilla-Quintana, Arantzazu Barquín, Jesús García-Donas
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 24(12)
The identification of subpopulations harboring druggable targets has become a major step forward in the subclassification of solid tumors into small groups suitable for specific therapies. BRAF fusions represent a paradigm of uncommon and targetable
Autor:
Luis Bote-Curiel, Sergio Ruiz-Llorente, Sergio Muñoz-Romero, Mónica Yagüe-Fernández, Arantzazu Barquín, Jesús García-Donas, José Luis Rojo-Álvarez
Publikováno v:
Expert Systems with Applications. 206:117865
Autor:
Martin Köbel, Eun‐Young Kang, Ashley Weir, Peter F Rambau, Cheng‐Han Lee, Gregg S Nelson, Prafull Ghatage, Nicola S Meagher, Marjorie J Riggan, Jennifer Alsop, Michael S Anglesio, Matthias W Beckmann, Christiani Bisinotto, Michelle Boisen, Jessica Boros, Alison H Brand, Angela Brooks‐Wilson, Michael E Carney, Penny Coulson, Madeleine Courtney‐Brooks, Kara L Cushing‐Haugen, Cezary Cybulski, Suha Deen, Mona A El‐Bahrawy, Esther Elishaev, Ramona Erber, Sian Fereday, AOCS Group, Anna Fischer, Simon A Gayther, Arantzazu Barquin‐Garcia, Aleksandra Gentry‐Maharaj, C Blake Gilks, Helena Gronwald, Marcel Grube, Paul R Harnett, Holly R Harris, Andreas D Hartkopf, Arndt Hartmann, Alexander Hein, Joy Hendley, Brenda Y Hernandez, Yajue Huang, Anna Jakubowska, Mercedes Jimenez‐Linan, Michael E Jones, Catherine J Kennedy, Tomasz Kluz, Jennifer M Koziak, Jaime Lesnock, Jenny Lester, Jan Lubiński, Teri A Longacre, Maria Lycke, Constantina Mateoiu, Bryan M McCauley, Valerie McGuire, Britta Ney, Alexander Olawaiye, Sandra Orsulic, Ana Osorio, Luis Paz‐Ares, Teresa Ramón y Cajal, Joseph H Rothstein, Matthias Ruebner, Minouk J Schoemaker, Mitul Shah, Raghwa Sharma, Mark E Sherman, Yurii B Shvetsov, Naveena Singh, Helen Steed, Sarah J Storr, Aline Talhouk, Nadia Traficante, Chen Wang, Alice S Whittemore, Martin Widschwendter, Lynne R Wilkens, Stacey J Winham, Javier Benitez, Andrew Berchuck, David D Bowtell, Francisco J Candido dos Reis, Ian Campbell, Linda S Cook, Anna DeFazio, Jennifer A Doherty, Peter A Fasching, Renée T Fortner, María J García, Marc T Goodman, Ellen L Goode, Jacek Gronwald, David G Huntsman, Beth Y Karlan, Linda E Kelemen, Stefan Kommoss, Nhu D Le, Stewart G Martin, Usha Menon, Francesmary Modugno, Paul DP Pharoah, Joellen M Schildkraut, Weiva Sieh, Annette Staebler, Karin Sundfeldt, Anthony J Swerdlow, Susan J Ramus, James D Brenton
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 9, Iss 3, Pp 208-222 (2023)
Abstract Our objective was to test whether p53 expression status is associated with survival for women diagnosed with the most common ovarian carcinoma histotypes (high‐grade serous carcinoma [HGSC], endometrioid carcinoma [EC], and clear cell carc
Externí odkaz:
https://doaj.org/article/493c5874781345c8971b7e798d52a02b
Autor:
Arantzazu Barquín-García, Elena Fernández-Sevillano, Paloma Navarro, Cristina Rodríguez-Antona, Monica Yague-Fernandez, Juan María Roldan-Romero, Juan Francisco Rodriguez-Moreno, Sergio Ruiz-Llorente, Raquel Martín, Sandra Amarilla-Quintana, Jesús García-Donas
Publikováno v:
Cancer Research. 80:5288-5288
Introduction The Fibroblast Growth Factor Receptor (FGFR) has become a key target in urothelial cancer. The FGFR inhibitor (FGFRi) erdafitinib has been approved for clinical use and many others are in development. Unfortunately, responses have shown
Autor:
Jesus Garcia-Donas, Diego Martínez-Urbistondo, Kyra Velázquez Kennedy, Paula Villares, Arántzazu Barquin, Andrea Dominguez, Juan Francisco Rodriguez-Moreno, Elena Caro, Rafael Suarez del Villar, Estanislao Nistal-Villan, Monica Yagüe, Maria Ortiz, Maria Barba, Sergio Ruiz-Llorente, Miguel Quiralte, Massimiliano Zanin, Cristina Rodríguez, Paloma Navarro, Pedro Berraondo, Rodrigo Madurga
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundManaging the inflammatory response to SARS-Cov-2 could prevent respiratory insufficiency. Cytokine profiles could identify cases at risk of severe disease.MethodsWe designed a randomized phase II clinical trial to determine whether the comb
Externí odkaz:
https://doaj.org/article/3ee849271a0c45228839d81a26042e68
Autor:
Luis Bote-Curiel, Sergio Ruiz-Llorente, Sergio Munoz-Romero, Monica Yague-Fernandez, Arantzazu Barquin, Jesus Garcia-Donas, Jose Luis Rojo-Alvarez
Publikováno v:
IEEE Access, Vol 9, Pp 25959-25972 (2021)
Ovarian cancer (OC) is the second most common gynecological malignancy and the gynecological tumor with the worst prognosis. To try to improve this situation, Data Science technologies could be a useful tool to help clinicians to know more about the
Externí odkaz:
https://doaj.org/article/8bb87a2d21eb4942a609f2c862f38042
Autor:
Luis Bote-Curiel, Sergio Ruiz-Llorente, Sergio Munoz-Romero, Monica Yague-Fernandez, Arantzazu Barquin, Jesus Garcia-Donas, Jose Luis Rojo-Alvarez
Publikováno v:
IEEE Access, Vol 9, Pp 58034-58051 (2021)
Developments of richer integrative analysis methods for oncological studies are needed for efficiently leveraging the amount of clinical and genetic data available to provide the clinicians with better information. However, analyses of this nature of
Externí odkaz:
https://doaj.org/article/5b73143ec7904fb39024b9024e315c53